Genes, Locations and Genetic Disorders on Chromosome 17

Last Updated: Sun Aug 6 22:00:02 EDT 2000
GeneGDB AccessionIDLocationOMIM Link
ABR GDB:11964217p13.3-17p13.3 ACTIVE BCR-RELATED GENE; ABR
ACACA GDB:12053417q21-17q21 17q12-17q12 ACETYL-CoA CARBOXYLASE DEFICIENCY
ACADVL GDB:124818517p13-17p13 17p11.2-17p11.1 ACYL-CoA DEHYDROGENASE, VERY-LONG-CHAIN, DEFICIENCY OF
ALDH10 GDB:131685517p11.2-17p11.2 SJOGREN-LARSSON SYNDROME; SLS
APOH GDB:11888717q23-17qter APOLIPOPROTEIN H; APOH
ASPA GDB:23101417pter-17p13 SPONGY DEGENERATION OF CENTRAL NERVOUS SYSTEM
BCL5 GDB:12517817q22-17q22 LEUKEMIA/LYMPHOMA, CHRONIC B-CELL, 5; BCL5
BLMH GDB:380146717q11.2-17q11.2 BLEOMYCIN HYDROLASE
BRCA1 GDB:12661117q21-17q21 17q11-17q21 BREAST CANCER, TYPE 1; BRCA1
CACD GDB:588580117p-17p 17p13-17p13 CHOROIDAL DYSTROPHY, CENTRAL AREOLAR; CACD
CCA1 GDB:11876317q24-17q24 CATARACT, CONGENITAL, CERULEAN TYPE 1; CCA1
CCZS GDB:68197317q11-17q12 CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS
CHRNB1 GDB:12058717p12-17p11 CHOLINERGIC RECEPTOR, NICOTINIC, BETA POLYPEPTIDE 1; CHRNB1
CHRNE GDB:13224617p13-17p12 CHOLINERGIC RECEPTOR, NICOTINIC, EPSILON POLYPEPTIDE; CHRNE
CMT1A GDB:11978517p12-17p11.2 17p11.2-17p11.2 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP
COL1A1 GDB:11906117q21.3-17q22 COLLAGEN, TYPE I, ALPHA-1 CHAIN; COL1A1
OSTEOGENESIS IMPERFECTA TYPE I
CORD5 GDB:56847317p13-17p12 CONE-ROD DYSTROPHY-5; CORD5
CORD6 GDB:559261517p13-17p12 CONE-ROD DYSTROPHY-6; CORD6
CTNS GDB:70076117p-17p 17p13-17p13 CYSTINOSIS, EARLY-ONSET OR INFANTILE NEPHROPATHIC TYPE
DCP1 GDB:11984017q23-17q23 DIPEPTIDYL CARBOXYPEPTIDASE-1; DCP1
DDPAC GDB:45477417q21-17q22 DISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX; DDPAC
ERBB2 GDB:12061317q11.2-17q12 17q21.1-17q21.1 V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ERBB2
G6PC GDB:23192717q21-17q21 GLYCOGEN STORAGE DISEASE I; GSD-I
GAA GDB:11996517q23-17q23 17q25.2-17q25.3 GLYCOGEN STORAGE DISEASE II
GALK1 GDB:11924617q24-17q24 17q23-17q25 GALACTOKINASE DEFICIENCY
GCGR GDB:30451617q25-17q25 GLUCAGON RECEPTOR; GCGR
GH1 GDB:11998217q22-17q24 17q23.1-17q23.3 GROWTH HORMONE 1; GH1
GH2 GDB:11998317q22-17q24 GROWTH HORMONE 2; GH2
GP1BA GDB:11880617pter-17p12 GIANT PLATELET SYNDROME
GPSC GDB:995456417q21-17q22 FAMILIAL PROGRESSIVE SUBCORTICAL
GUCY2D GDB:13601217p13-17p13 AMAUROSIS CONGENITA OF LEBER I
GUANYLATE CYCLASE 2D, MEMBRANE; GUC2D
ITGA2B GDB:12001217q21.32-17q21.32 THROMBASTHENIA OF GLANZMANN AND NAEGELI
ITGB3 GDB:12001317q21.32-17q21.32 INTEGRIN, BETA-3; ITGB3
ITGB4 GDB:12802817q11-17qter INTEGRIN, BETA-4; ITGB4
KRT10 GDB:11882817q12-17q21 17q21-17q22 KERATIN 10; KRT10
KRT12 GDB:558395317q11-17q12 17q12-17q12 CORNEAL DYSTROPHY, JUVENILE EPITHELIAL, OF MEESMANN
KERATIN 12; KRT12
KRT13 GDB:12074017q21-17q23 17q21-17q22 KERATIN 13; KRT13
KRT14 GDB:13214517q12-17q21 KERATIN 14; KRT14
GLUTATHIONE SYNTHETASE; GSS
KRT14L1 GDB:12012117p12-17p11 17q12-17q21 KERATIN 14; KRT14
KRT14L2 GDB:12012217p12-17p11 17q12-17q21 KERATIN 14; KRT14
KRT14L3 GDB:12012317p12-17p11 17q12-17q21 KERATIN 14; KRT14
KRT16 GDB:13620717pter-17qter 17q12-17q21 KERATIN 16; KRT16
KRT16L1 GDB:12012517p12-17p11 17q12-17q21 KERATIN 16; KRT16
KRT16L2 GDB:12012617p12-17p11 17q12-17q21 KERATIN 16; KRT16
KRT17 GDB:13621117q12-17q21 KERATIN 17; KRT17
KRT9 GDB:30397017q12-17q21 HYPERKERATOSIS, LOCALIZED EPIDERMOLYTIC
MAPT GDB:11943417q21-17q21 MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT
PALLIDOPONTONIGRAL DEGENERATION; PPND
MDB GDB:995895917p13.1-17p12 MEDULLOBLASTOMA; MDB
MDCR GDB:12052517p13.3-17p13.3 MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS
PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, GAMMA SUBUNIT
MGI GDB:995455017p13-17p13 MYASTHENIA GRAVIS, FAMILIAL INFANTILE; FIMG
MHS2 GDB:13258017q11.2-17q24 MALIGNANT HYPERTHERMIA SUSCEPTIBILITY-2; MHS2
MKS GDB:68196717q21-17q24 MECKEL SYNDROME; MKS
MPO GDB:12019217q21.3-17q23 17q23.1-17q23.1 MYELOPEROXIDASE DEFICIENCY
MUL GDB:63605017q-17q 17q21.3-17q21.3 MULIBREY NANISM; MUL
MYO15 GDB:983800617p11.2-17p11.2 DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE, 3; DFNB3
NAGLU GDB:63653317q21.1-17q21.1 MUCOPOLYSACCHARIDOSIS TYPE IIIB
NAPB GDB:995457217q25-17q25 NEURITIS WITH BRACHIAL PREDILECTION; NAPB
NF1 GDB:12023117q11.2-17q11.2 NEUROFIBROMATOSIS, TYPE I; NF1
NME1 GDB:12796517q21-17q22 17q21.3-17q21.3 NON-METASTATIC CELLS 1, PROTEIN EXPRESSED IN; NME1
P4HB GDB:12070817q25-17q25 PROLYL-4-HYDROXYLASE, BETA POLYPEPTIDE; PHDB; PROHB
PAFAH1B1 GDB:67743017p13.3-17p13.3 PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, GAMMA SUBUNIT
PCHC1 GDB:40764117q12-17q21 PACHYONYCHIA CONGENITA, JACKSON-LAWLER TYPE
PECAM1 GDB:69637217q23-17q23 PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE; PECAM1
PHA2B GDB:995456617q21-17q22 PSEUDOHYPOALDOSTERONISM TYPE II, LOCUS B; PHA2B
PHB GDB:12660017q21-17q21 PROHIBITIN; PHB
PLI GDB:12030117p13-17p13 PLASMIN INHIBITOR DEFICIENCY
PMP22 GDB:13419017p11.2-17p11.2 17p12-17p11.2 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
PERIPHERAL MYELIN PROTEIN 22; PMP22
PRKCA GDB:12801517q22-17q24 17q22-17q23.2 PROTEIN KINASE C, ALPHA; PRKCA
PTLAH GDB:995734217q-17q APLASIA OR HYPOPLASIA
RARA GDB:12033717q12-17q12 RETINOIC ACID RECEPTOR, ALPHA; RARA
RCV1 GDB:13547717p13-17p12 17p13.1-17p13.1 RECOVERIN; RCV1
RMSA1 GDB:30451917p12-17p11.2 REGULATOR OF MITOTIC SPINDLE ASSEMBLY 1; RMSA1
RP13 GDB:39264717p13.3-17p13.2 17p13.3-17p13.3 17p-17p RETINITIS PIGMENTOSA-13; RP13
RP17 GDB:68319917q22-17q24 17q22-17q22 RETINITIS PIGMENTOSA-17; RP17
RSS GDB:43924917q25-17q25 RUSSELL-SILVER SYNDROME; RSS
SCN4A GDB:12518117q22-17q24 17q23.1-17q25.3 PERIODIC PARALYSIS II
SGCA GDB:38407717q21-17q21 ADHALIN; ADL
SGSH GDB:131910117q25.3-17q25.3 MUCOPOLYSACCHARIDOSIS TYPE IIIA
SHBG GDB:12528017pter-17p12 SEX HORMONE BINDING GLOBULIN; SHBG
SLC2A4 GDB:11999717p13-17p13 SOLUTE CARRIER FAMILY 2, MEMBER 4; SLC2A4
SLC4A1 GDB:11987417q12-17q21 17q21-17q22 SOLUTE CARRIER FAMILY 4, ANION EXCHANGER, MEMBER 1; SLC4A1
SLC6A4 GDB:13471317q11.1-17q12 17q12-17q12 SOLUTE CARRIER FAMILY 6, MEMBER 4; SLC6A4
SMCR GDB:12037917p11.2-17p11.2 SMITH-MAGENIS SYNDROME; SMS
SOX9 GDB:13473017q24.3-17q25.1 CAMPOMELIC DYSPLASIA; CMD1
SSTR2 GDB:13418617q24-17q24 SOMATOSTATIN RECEPTOR-2; SSTR2
SYM1 GDB:51217417q21-17q22 SYMPHALANGISM, PROXIMAL; SYM1
SYNS1 GDB:986234317q21-17q22 SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY
TCF2 GDB:12529817q11.2-17q12 TRANSCRIPTION FACTOR-2, HEPATIC; TCF2
THRA GDB:12073017q11.2-17q12 THYROID HORMONE RECEPTOR, ALPHA-2; THRA2
THYROID HORMONE RECEPTOR, ALPHA 1; THRA
TIMP2 GDB:13261217q25-17q25 TISSUE INHIBITOR OF METALLOPROTEINASE-2; TIMP2
TOC GDB:45197817q24-17q24 17q23-17qter TYLOSIS WITH ESOPHAGEAL CANCER; TOC
TOP2A GDB:11888417q21-17q22 TOPOISOMERASE (DNA) II, ALPHA; TOP2A
TP53 GDB:12044517p13.1-17p13.1 TUMOR PROTEIN p53; TP53
VBCH GDB:995455417q11.2-17q11.2 HYPEROSTOSIS CORTICALIS GENERALISATA